Aberrant cyclooxygenase isozyme expression in human intrahepatic cholangiocarcinoma. - Wikidata - wikimedia - TriplyDB

Aberrant cyclooxygenase isozyme expression in human intrahepatic cholangiocarcinoma.

Aberrant cyclooxygenase isozyme expression in human intrahepatic cholangiocarcinoma.

http://www.wikidata.org/entity/Q35362299

about

Hepatolithiasis and intrahepatic cholangiocarcinoma: A review.MicroRNA-26a promotes cholangiocarcinoma growth by activating β-catenin miR-21 targets 15-PGDH and promotes cholangiocarcinoma growth.Cyclooxygenase-2-derived prostaglandin E2 promotes human cholangiocarcinoma cell growth and invasion through EP1 receptor-mediated activation of the epidermal growth factor receptor and Akt.Reappraisal of the therapeutic role of celecoxib in cholangiocarcinoma.Microsomal prostaglandin E synthase-1 inhibits PTEN and promotes experimental cholangiocarcinogenesis and tumor progression.Omega-3 Polyunsaturated Fatty Acids Upregulate 15-PGDH Expression in Cholangiocarcinoma Cells by Inhibiting miR-26a/b Expression.Immunodetection of cyclooxygenase-2 (COX-2) is restricted to tissue macrophages in normal rat liver and to recruited mononuclear phagocytes in liver injury and cholangiocarcinoma Elevated expression of cyclooxygenase-2 is a negative prognostic factor for overall survival in intrahepatic cholangiocarcinoma.Cyclooxygenase in normal human tissues--is COX-1 really a constitutive isoform, and COX-2 an inducible isoform?Proliferative activity of bile from congenital choledochal cyst patients What are cyclooxygenases and lipoxygenases doing in the driver's seat of carcinogenesis?Role of ErbB family receptor tyrosine kinases in intrahepatic cholangiocarcinoma miR-101 inhibits cholangiocarcinoma angiogenesis through targeting vascular endothelial growth factor (VEGF).Down-regulation of miR-214 contributes to intrahepatic cholangiocarcinoma metastasis by targeting Twist.Inducible nitric oxide synthase upregulates cyclooxygenase-2 in mouse cholangiocytes promoting cell growth.COX-2 inhibits Fas-mediated apoptosis in cholangiocarcinoma cells.Expression of cyclooxygenase-2 in cholangiocarcinoma: correlation with clinicopathological features and prognosis.Arterial stiffness induces remodeling phenotypes in pulmonary artery smooth muscle cells via YAP/TAZ-mediated repression of cyclooxygenase-2.A selective cyclooxygenase-2 inhibitor (Etodolac) prevents spontaneous biliary tumorigenesis in a hamster bilioenterostomy model.A novel positive feedback loop between peroxisome proliferator-activated receptor-delta and prostaglandin E2 signaling pathways for human cholangiocarcinoma cell growth.Potential candidate treatment agents for targeting of cholangiocarcinoma identified by gene expression profile analysis.

P2860

Q26771199-3F60DF69-89F1-46E9-A630-C1B1D48101C7 Q28263940-7BE5088A-F68A-4E3C-BE85-EFA8487E639E Q33758343-37CAECDC-EB0C-42BB-85EC-A6CDF1BC1FD6 Q34414026-A0F4F5C4-3AE1-4CDA-A0E7-15DF85C44A3A Q34904867-AE3D3AA4-8C4B-41FB-B1CE-55F2543A2CC7 Q35028164-8586DFFD-F8B9-41FD-8D36-E413D14F8653 Q35251736-89E7EE3F-F310-489C-8847-B32213F088EA Q35683401-488DE490-BB68-4101-9CE1-33D4F1052935 Q35837128-54780C98-A939-4700-A970-7C4E72F7883D Q35893380-D7577B8E-DDC9-4DEB-BCD0-9E72CB13610D Q36506347-B6E2FECB-994C-4866-A67E-8EA48C8F9ABE Q36572139-B16F5C90-2E8C-4D8D-B567-49CC289E91A9 Q37351498-603EF3A2-A3E0-4BE4-8699-06C25520611E Q39162380-A42F86CE-1E4E-4DF8-9FDC-BE68D1048DBD Q39357431-0FABC7A4-A79E-4A9F-B622-B60E53AEEB25 Q40587280-B567A3A2-A4CE-4BFE-8E23-4E5A55811360 Q40747791-F82B49CB-093F-4B88-990E-C3B74BB8120F Q44360204-06EEF97D-DC8A-447A-916F-F8261DDE520A Q47993375-D2587DEA-6F94-4077-99BE-2F6E3C2646FE Q51748783-92FF5772-5207-4E55-BBBE-73BB3A29D8FB Q53600002-1212B4F5-208D-4FAE-861F-67930692815B Q55248371-FA673FEE-551D-4DBF-9566-5A25AA612786

P2860

Aberrant cyclooxygenase isozyme expression in human intrahepatic cholangiocarcinoma.

http://www.wikidata.org/entity/Q35362299

description

2001 nî lūn-bûn

@nan

2001 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Aberrant cyclooxygenase isozyme expression in human intrahepatic cholangiocarcinoma.

@ast

Aberrant cyclooxygenase isozyme expression in human intrahepatic cholangiocarcinoma.

@en

type

label

Aberrant cyclooxygenase isozyme expression in human intrahepatic cholangiocarcinoma.

@ast

Aberrant cyclooxygenase isozyme expression in human intrahepatic cholangiocarcinoma.

@en

prefLabel

Aberrant cyclooxygenase isozyme expression in human intrahepatic cholangiocarcinoma.

@ast

Aberrant cyclooxygenase isozyme expression in human intrahepatic cholangiocarcinoma.

@en

P1433

Q35362299-0C4B2EF9-0716-4315-B5B2-B92FD2B508D0

P1476

Q35362299-9C581A5A-C442-4CC8-B1F7-8FE3914FBB46

P2093

Q35362299-415C1073-1CD5-49D6-A6F8-B58723B83033

Q35362299-5264583B-C9D8-47BF-AAE4-67E77FB1340B

Q35362299-59ECDE7A-9D47-4941-B632-4235CC03891D

Q35362299-656FF318-BCB3-44BA-8A46-0F3A9B019007

Q35362299-6641502A-42DF-462F-B71A-475EBD4F17EC

Q35362299-6FEEA70E-2D29-43E3-9BAA-E5D9D538033F

Q35362299-F7B70775-C6A1-4016-81EE-EEDE2ECBBD03

P2860

Q35362299-07A0ED78-7E55-445F-B8F0-F47DC4FB133E

Q35362299-156546FD-1CA1-442E-9FF7-4876A485E4A6

Q35362299-174910A1-8684-4185-B1B2-AB958AF67328

Q35362299-1B1CF8D4-8011-41A6-9267-4377F83B10D4

Q35362299-254DA311-839E-492F-BE14-9F0626CEEB4D

Q35362299-263CCE35-B24F-4E94-B973-0226333DB5EA

Q35362299-27C4C846-771B-4FDD-90C2-4A60BC830FA3

Q35362299-28AF72F6-5B60-4D29-B8E3-88E33289C352

Q35362299-2C805B2E-A19C-4C29-849E-67C23F74ED6E

Q35362299-2F2E12BE-87A2-4C06-91E7-96AC31B8DCA2

P304

Q35362299-8A92CF9A-28C1-41C0-9728-F83FD5E1E5F6

P31

Q35362299-F8C15715-2853-41F4-B600-F34CBBE5235F

P356

Q35362299-A1DBDF10-FE68-4214-9462-144B8902F2E1

P407

Q35362299-A74455F5-076D-440F-A208-269D754F96F6

P433

Q35362299-7707CD95-71E0-492B-8006-61CF71A6314F

P478

Q35362299-654ABDF3-9E5F-4D45-B087-19049D045697

P577

Q35362299-F5AA604C-A78B-43EF-AF6F-92B0B9BD54ED

P5875

Q35362299-5E3DCC88-4018-4171-B60C-2E3BA20035F4

P698

Q35362299-CB746044-581D-4D75-818C-846ED8F89248

P921

Q35362299-2CF95D1B-8556-4A6C-9302-1538C10BE996

P932

Q35362299-7ECD50DA-B6E8-4CD5-B262-61AEE83150A6

P356

P1433

P1476

Aberrant cyclooxygenase isozyme expression in human intrahepatic cholangiocarcinoma.

@en

P2093

Chariyalertsak S

http://www.w3.org/2001/XMLSchema#string

Fürstenberger G

http://www.w3.org/2001/XMLSchema#string

Kopp-Schneider A

http://www.w3.org/2001/XMLSchema#string

Marks F

http://www.w3.org/2001/XMLSchema#string

Mayer D

http://www.w3.org/2001/XMLSchema#string

Müller-Decker K

http://www.w3.org/2001/XMLSchema#string

Sirikulchayanonta V

http://www.w3.org/2001/XMLSchema#string

P2860

Cyclooxygenase in biology and disease.

Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues

Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)

Cyclooxygenases 1 and 2

Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas

Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis.

Expression of cyclooxygenase-2 in human lung carcinoma.

Eicosanoids and multistage carcinogenesis in NMRI mouse skin: role of prostaglandins E and F in conversion (first stage of tumor promotion) and promotion (second stage of tumor promotion).

Pharmacological analysis of cyclooxygenase-1 in inflammation

Proliferative responses of the skin to external stimuli

P304

80-86

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/GUT.48.1.80

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

48

http://www.w3.org/2001/XMLSchema#string

P577

2001-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12212175

http://www.w3.org/2001/XMLSchema#string

P698

11115827

http://www.w3.org/2001/XMLSchema#string

P921

cholangiocarcinoma

P932

1728157

http://www.w3.org/2001/XMLSchema#string